ZNF215 Activators
ZNF215 can initiate a cascade of intracellular events leading to its activation through various signaling pathways. Forskolin, for instance, directly targets adenylate cyclase, elevating cAMP levels within the cell. This surge in cAMP activates protein kinase A (PKA), which can phosphorylate ZNF215, thereby enhancing its DNA-binding activity and influencing cellular functions. Similarly, agents such as Isoproterenol also act to increase cAMP concentrations, thus further stimulating PKA and its subsequent action on ZNF215. Dibutyryl-cAMP and 8-Br-cAMP, both being cAMP analogs, bypass upstream receptors and directly activate PKA, streamlining the pathway straight to the phosphorylation step and subsequent activation of ZNF215.
Other chemicals operate through different mechanisms to modulate ZNF215. PMA, for example, is a potent activator of protein kinase C (PKC), which phosphorylates serine and threonine residues on target proteins, possibly including ZNF215, to modulate its conformation or interaction with other proteins. Anisomycin, through its ability to activate stress-activated protein kinases like JNK, can also contribute to the phosphorylation and thus the functional readiness of ZNF215. EGF and IGF-1 both engage their respective receptors to trigger the MAPK/ERK pathway, which harbors a suite of kinases capable of modifying ZNF215. Insulin similarly can activate the PI3K/Akt signaling pathway, leading to the phosphorylation of various substrates that may interact with or modulate the activity of ZNF215. Lastly, calcium ionophores such as Ionomycin and A23187, as well as SERCA inhibitors like Thapsigargin, lead to elevated intracellular calcium levels, which activate calcium-dependent protein kinases. These kinases then have the capacity to phosphorylate ZNF215, thus influencing its role in cellular signaling and function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can then phosphorylate serine and threonine residues on various proteins. PKC-mediated phosphorylation can result in the functional activation of ZNF215 by potentially altering its conformation or interaction with other proteins. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium can activate calcium-dependent protein kinases, such as CaMKII, which may then phosphorylate and activate ZNF215 by changing its conformation or promoting its interaction with other regulatory proteins. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin can activate the PI3K/Akt signaling pathway, which is known to regulate various cellular functions through phosphorylation of multiple proteins. Akt can phosphorylate substrates that may interact with or regulate ZNF215, leading to its functional activation. | ||||||
IGF-1R Inhibitor, PPP | 477-47-4 | sc-204008A sc-204008 sc-204008B | 1 mg 10 mg 100 mg | $138.00 $203.00 $895.00 | 63 | |
Insulin-like Growth Factor 1 (IGF-1) triggers the IGF-1 receptor, causing activation of the PI3K/Akt and MAPK/ERK pathways, which could lead to post-translational modifications of ZNF215, promoting its activation and function in the cell. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol acts on beta-adrenergic receptors, stimulating the production of cAMP, which activates PKA. PKA then potentially phosphorylates proteins including ZNF215, leading to its activation in cellular signaling pathways. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is known to activate stress-activated protein kinases like JNK. JNK can phosphorylate various transcription factors and could potentially phosphorylate ZNF215, which may enhance its functional activity within the nucleus. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates PKA. PKA can phosphorylate and thus activate ZNF215, influencing its role in gene regulation and cellular processes. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Bromoadenosine 3',5'-cyclic monophosphate (8-Br-cAMP) is a cAMP analog that activates PKA. Activated PKA can phosphorylate ZNF215, which may lead to its activation and influence on gene expression patterns. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium levels, which activates calcium-dependent protein kinases that could phosphorylate and activate ZNF215. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore like ionomycin, increasing intracellular Ca2+ concentration, which activates calcium-dependent protein kinases that may phosphorylate and thus activate ZNF215. | ||||||